Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals
Open Access
- 12 November 2015
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 27 (5), 1495-1504
- https://doi.org/10.1681/asn.2015040373
Abstract
Among patients with ESRD, cancer risk is affected by kidney dysfunction and by immunosuppression after transplant. Assessing patterns across periods of dialysis and kidney transplantation may inform cancer etiology. We evaluated 202,195 kidney transplant candidates and recipients from a linkage between the Scientific Registry of Transplant Recipients and cancer registries, and compared incidence in kidney function intervals (time with a transplant) with incidence in nonfunction intervals (waitlist or time after transplant failure), adjusting for demographic factors. Incidence of infection-related and immune-related cancer was higher during kidney function intervals than during nonfunction intervals. Incidence was most elevated for Kaposi sarcoma (hazard ratio [HR], 9.1; 95% confidence interval (95% CI), 4.7 to 18), non-Hodgkin’s lymphoma (HR, 3.2; 95% CI, 2.8 to 3.7), Hodgkin’s lymphoma (HR, 3.0; 95% CI, 1.7 to 5.3), lip cancer (HR, 3.4; 95% CI, 2.0 to 6.0), and nonepithelial skin cancers (HR, 3.8; 95% CI, 2.5 to 5.8). Conversely, ESRD-related cancer incidence was lower during kidney function intervals (kidney cancer: HR, 0.8; 95% CI, 0.7 to 0.8 and thyroid cancer: HR, 0.7; 95% CI, 0.6 to 0.8). With each successive interval, incidence changed in alternating directions for non-Hodgkin’s lymphoma, melanoma, and lung, pancreatic, and nonepithelial skin cancers (higher during function intervals), and kidney and thyroid cancers (higher during nonfunction intervals). For many cancers, incidence remained higher than in the general population across all intervals. These data indicate strong short-term effects of kidney dysfunction and immunosuppression on cancer incidence in patients with ESRD, suggesting a need for persistent cancer screening and prevention.Keywords
This publication has 32 references indexed in Scilit:
- Risk of Kaposi sarcoma during the first months on combination antiretroviral therapyAIDS, 2013
- Cancer risk among elderly persons with end-stage renal disease: a population-based case–control studyBMC Nephrology, 2012
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Pulmonary Infections and Risk of Lung Cancer Among Persons With AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant RecipientsCancer Epidemiology, Biomarkers & Prevention, 2009
- Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantationBlood, 2009
- A review of human carcinogens—Part B: biological agentsPublished by Elsevier BV ,2009
- Immunosuppression and Other Risk Factors for Lip Cancer after Kidney TransplantationCancer Epidemiology, Biomarkers & Prevention, 2009
- Cancer in patients on dialysis and after renal transplantationNephrology Dialysis Transplantation, 2008
- A Simple Multivariate Test for One-Sided AlternativesJournal of the American Statistical Association, 1996